Parschauer Karah Herdman

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
18 0% Buy
34 71% Buy
47 69% Buy
Parschauer Karah Herdman's trades of Ultragenyx Pharmaceutical Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-10 2026-03-10 PrS Proposed sale
7,935
341.35
US$1,745,631
7,935 341.35 US$1,745,631
2026-03-10 2026-03-10 S Sale
15,042 -43.3%
425.19
US$27,860
15,042 -43.3% 425.19 US$27,860
2026-03-10 2026-03-06 S Sale
25,696 -33.8%
478.41
US$4,814,925
25,696 -33.8% 478.41 US$4,814,925
2026-03-06 2026-03-06 PrS Proposed sale
6,018
21.40
US$128,775
6,018 21.40 US$128,775
2026-03-03 2026-03-02 PlS Planned sale
8,135 -9.6%
22.80
US$185,478
8,135 -9.6% 22.80 US$185,478
2025-09-12 2025-09-12 PrS Proposed sale
2,450
31.17
US$76,366
2,450 31.17 US$76,366
2025-09-12 2025-09-12 PlS Planned sale
2,450 -3.2%
31.17
US$76,366
2,450 -3.2% 31.17 US$76,366
2025-03-14 2025-03-12 S Sale
12,888 -28.6%
12.99
US$167,465
12,888 -28.6% 12.99 US$167,465
2025-03-12 2025-03-12 PrS Proposed sale
12,888
12.99
US$167,465
12,888 12.99 US$167,465
2025-03-04 2025-03-03 S Sale
12,846 -14.6%
42.10
US$540,817
12,846 -14.6% 42.10 US$540,817
2025-03-03 2025-02-27 S Sale
760 -1.4%
42.75
US$32,490
760 -1.4% 42.75 US$32,490
2025-03-03 2025-02-27 S Sale
2,230 -3.8%
42.93
US$95,734
2,230 -3.8% 42.93 US$95,734
2025-02-27 2025-02-27 PrS Proposed sale
2,990
42.88
US$128,215
2,990 42.88 US$128,215
2024-06-12 2024-06-12 PrS Proposed sale
9,806
45.00
US$441,270
9,806 45.00 US$441,270
2024-06-12 2024-06-12 PlS Planned sale
9,806 -14.5%
45.00
US$441,270
9,806 -14.5% 45.00 US$441,270
2024-03-05 2024-03-01 PlS Planned sale
3,756 -5.3%
53.76
US$201,923
3,756 -5.3% 53.76 US$201,923
2024-02-02 2024-01-30 S Sale
11,931 -27.6%
13.14
US$156,733
11,931 -27.6% 13.14 US$156,733
2024-01-30 2024-01-30 PrS Proposed sale
11,931
13.14
US$156,732
11,931 13.14 US$156,732
2023-05-05 2023-05-04 PlS Planned sale
4,378 -7.8%
45.00
US$197,010
4,378 -7.8% 45.00 US$197,010
2023-05-04 2023-05-04 PrS Proposed sale
4,378
45.00
US$197,010
4,378 45.00 US$197,010
2023-03-03 2023-03-01 PlS Planned sale
3,161 -5.3%
45.25
US$143,035
3,161 -5.3% 45.25 US$143,035
2022-03-08 2022-03-07 S Sale
5,140 -13.0%
62.95
US$323,563
5,140 -13.0% 62.95 US$323,563
2022-03-03 2022-03-01 S Sale
2,886 -10.2%
66.62
US$192,265
2,886 -10.2% 66.62 US$192,265
2021-10-18 2021-10-14 S Sale
310 -1.1%
81.14
US$25,153
310 -1.1% 81.14 US$25,153
2021-05-10 2021-05-06 PlS Planned sale
313 -1.0%
113.67
US$35,579
313 -1.0% 113.67 US$35,579
2021-03-03 2021-03-01 S Sale
3,970 -11.6%
138.17
US$548,535
3,970 -11.6% 138.17 US$548,535
2020-11-02 2020-10-30 PlS Planned sale
9,903 -29.2%
100.12
US$991,488
9,903 -29.2% 100.12 US$991,488
2020-10-30 2020-10-28 S Sale
97 -0.4%
100.00
US$9,700
97 -0.4% 100.00 US$9,700
2020-10-16 2020-10-14 S Sale
325 -1.3%
88.00
US$28,600
325 -1.3% 88.00 US$28,600
2020-10-13 2020-10-08 S Sale
10,000 -29.2%
95.00
US$950,000
10,000 -29.2% 95.00 US$950,000
2020-10-07 2020-10-06 S Sale
10,000 -29.2%
90.00
US$900,000
10,000 -29.2% 90.00 US$900,000
2020-09-24 2020-09-23 S Sale
10,000 -29.2%
85.00
US$850,000
10,000 -29.2% 85.00 US$850,000
2020-08-19 2020-08-17 S Sale
2,370 -8.9%
88.39
US$209,484
2,370 -8.9% 88.39 US$209,484
2020-08-19 2020-08-17 S Sale
10,000 -27.3%
88.44
US$884,400
10,000 -27.3% 88.44 US$884,400
2020-05-19 2020-05-18 PlS Planned sale
2,722 -9.1%
74.72
US$203,374
2,722 -9.1% 74.72 US$203,374
2019-06-24 2019-06-24 PlS Planned sale
1,226 -6.5%
61.50
US$75,399
1,226 -6.5% 61.50 US$75,399
2019-06-24 2019-06-21 PlS Planned sale
1,489 -7.3%
63.01
US$93,822
1,489 -7.3% 63.01 US$93,822
2019-04-30 2019-04-29 PlS Planned sale
468 -2.3%
68.30
US$31,964
468 -2.3% 68.30 US$31,964